Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer

Filtrer
Letter
2018

Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes

Grarup, N., Moltke, I., Andersen, M. K., Dalby, M., Vitting-Seerup, K., Kern, T., Mahendran, Y., Jørsboe, E., Larsen, C. V. L., Dahl-Petersen, I. K., Gilly, A., Suveges, D., Dedoussis, G., Zeggini, E., Pedersen, O., Andersson, R., Bjerregaard, P., Jørgensen, M. E., Albrechtsen, A. & Hansen, T., feb. 2018, I : Nature Genetics. 50, 2, s. 172–174

Publikation: Bidrag til tidsskriftLetterForskningpeer review

Åben adgang
Fil
103 Downloads (Pure)

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study

the CVD-REAL Investigators and Study Group, 1. aug. 2018, I : Diabetes, Obesity and Metabolism. 20, 8, s. 1983-1987

Publikation: Bidrag til tidsskriftLetterForskningpeer review

Åben adgang
Fil
118 Downloads (Pure)
2017
Åben adgang
Fil
111 Downloads (Pure)

Incidence of ketoacidosis in the danish type 2 diabetes population before and after introduction of sodium-glucose cotransporter 2 inhibitorsda nationwide, retrospective cohort study, 1995-2014

Jensen, M. L., Persson, F., Andersen, G. S., Ridderstråle, M., Nolan, J. J., Carstensen, B. & Jørgensen, M. E., 2017, I : Diabetes Care. 40, 5, s. e57-e58

Publikation: Bidrag til tidsskriftLetterForskningpeer review